Traditionally recognized for orchestrating antioxidant defence via the transcriptional activation of cytoprotective genes (e.g., HMOX1, NQO1, GCLC), Nrf2 is now understood to modulate a broader spectrum of cellular processes directly implicated in ALS pathogenesis [41,131,132]. This evidence concerns the gene NFE2L2 and amyotrophic lateral sclerosis.